GeneSight Mental Health Monitor Media Kit: 8% Remain Hopeful
Only 8% of people remain hopeful after depression medication fails them, according to GeneSight® Mental Health Monitor nationwide survey
SALT LAKE CITY, September 8, 2021 – Depression medication trial and error is far too common – and may result in additional mental health challenges.
The GeneSight Mental Health Monitor is a nationwide survey conducted by ACUPOLL Precision Research, Inc. during Aug.-Sept. 2021 among a statistically representative sample of adults age 21+, including a representative sample diagnosed with anxiety. The margin of error in survey results for the total base population at a 95% confidence interval is +/- 3%.